Vajpayee et al.  studied the mTOR marker among the diffuse large B cell lymphoma patients and revealed that the high mTOR expression showed a trend toward advanced clinical stage than others (78% vs. 54%, p = 0.08) [46]. Here, MTOR is linked to diffuse large B-cell lymphoma.